本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Jasper Therapeutics

1.86
0.0000
盤後1.910.0500+2.69%18:51 EST
成交量:139.50萬
成交額:264.13萬
市值:5,205.03萬
市盈率:-0.32
高:1.96
開:1.84
低:1.81
收:1.86
52周最高:22.99
52周最低:1.39
股本:2,798.40萬
流通股本:2,281.03萬
量比:1.91
換手率:6.12%
股息:- -
股息率:- -
每股收益(TTM):-5.7868
每股收益(LYR):-4.8865
淨資產收益率:-191.12%
總資產收益率:-72.92%
市淨率:4.50
市盈率(LYR):-0.38

資料載入中...

2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/06/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/27

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report